Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1503/cmaj.140816 http://scihub22266oqcxt.onion/10.1503/cmaj.140816 C4347789!4347789!25646289     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       CMAJ 2015 ; 187 (4): E138-43 Nephropedia Template TP {{tp|p=25646289|t=2015. Trimethoprim?sulfamethoxazole and risk of sudden death among patients taking spironolactone |pdf=|usr=}}{{25646289}} gab.com Text Trimethoprim sulfamethoxazole and risk of sudden death among patients taking spironolactone JO: CMAJ http://www.kidney.de/pget.php?&tw=1&pmid=25646289 #FOAvip Background:: Trimethoprim?sulfamethoxazole increases the risk of hyperkalemia when used with spironolactone. We examined whether this drug combination is associated with an increased risk of sudden death, a consequence of severe hyperkalemia. Methods:: We conducted a population-based nested case?control study involving Ontario residents aged 66 years or older who received spironolactone between Apr. 1, 1994, and Dec. 31, 2011. Within this group, we identified cases as patients who died of sudden death within 14 days after receiving a prescription for trimethoprim?sulfamethoxazole or one of the other study antibiotics (amoxicillin, ciprofloxacin, norfloxacin or nitrofurantoin). For each case, we identified up to 4 controls matched by age and sex. We determined the odds ratio (OR) for the association between sudden death and exposure to each antibiotic relative to amoxicillin, adjusted for predictors of sudden death using a disease risk index. Results:: Of the 11 968 patients who died of sudden death while receiving spironolactone, we identified 328 whose death occurred within 14 days after antibiotic exposure. Compared with amoxicillin, trimethoprim?sulfamethoxazole was associated with a more than twofold increase in the risk of sudden death (adjusted OR 2.46, 95% confidence interval [CI] 1.55?3.90). Ciprofloxacin (adjusted OR 1.55, 95% CI 1.02?2.38) and nitrofurantoin (adjusted OR 1.70, 95% CI 1.03?2.79) were also associated with an increased risk of sudden death, although the risk with nitrofurantoin was not apparent in a sensitivity analysis. Interpretation:: The antibiotic trimethoprim?sulfamethoxazole was associated with an increased risk of sudden death among older patients taking spironolactone. When clinically appropriate, alternative antibiotics should be considered in these patients. Twit Text FOAVip Trimethoprim sulfamethoxazole and risk of sudden death among patients taking spironolactone ????CMAJ http://www.kidney.de/pget.php?&tw=1&pmid=25646289 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25646289 #FOAvip English Wikipedia <ref>{{Cite pmid|25646289}}</ref> Trimethoprim?sulfamethoxazole and risk of sudden death among patients taking spironolactone #MMPMID25646289 Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN CMAJ 2015[Mar]; 187 (4): E138-43 PMID25646289show ga Background:: Trimethoprim?sulfamethoxazole increases the risk of hyperkalemia when used with spironolactone. We examined whether this drug combination is associated with an increased risk of sudden death, a consequence of severe hyperkalemia. Methods:: We conducted a population-based nested case?control study involving Ontario residents aged 66 years or older who received spironolactone between Apr. 1, 1994, and Dec. 31, 2011. Within this group, we identified cases as patients who died of sudden death within 14 days after receiving a prescription for trimethoprim?sulfamethoxazole or one of the other study antibiotics (amoxicillin, ciprofloxacin, norfloxacin or nitrofurantoin). For each case, we identified up to 4 controls matched by age and sex. We determined the odds ratio (OR) for the association between sudden death and exposure to each antibiotic relative to amoxicillin, adjusted for predictors of sudden death using a disease risk index. Results:: Of the 11 968 patients who died of sudden death while receiving spironolactone, we identified 328 whose death occurred within 14 days after antibiotic exposure. Compared with amoxicillin, trimethoprim?sulfamethoxazole was associated with a more than twofold increase in the risk of sudden death (adjusted OR 2.46, 95% confidence interval [CI] 1.55?3.90). Ciprofloxacin (adjusted OR 1.55, 95% CI 1.02?2.38) and nitrofurantoin (adjusted OR 1.70, 95% CI 1.03?2.79) were also associated with an increased risk of sudden death, although the risk with nitrofurantoin was not apparent in a sensitivity analysis. Interpretation:: The antibiotic trimethoprim?sulfamethoxazole was associated with an increased risk of sudden death among older patients taking spironolactone. When clinically appropriate, alternative antibiotics should be considered in these patients. äTrimethoprim?sulfamethoxazole and risk of sudden death among patients (epmc).pdf DeepDyve Pubget Overpricing